Compare Sustiva (Efavirenz) with Alternative HIV Medications
HIV Medication Switching Calculator
Assess Your Situation
This tool helps you evaluate whether switching from Sustiva (efavirenz) to alternative HIV medications might be beneficial based on your symptoms and medical circumstances.
Your Assessment
Recommendation
Your assessment results will appear here after you complete the questionnaire.
Key Findings
Potential Alternatives
| Medication | Best For | Side Effects | First-Line? |
|---|
Next Steps
Sustiva (efavirenz) has been a cornerstone of HIV treatment for over two decades. It’s part of the NNRTI class-non-nucleoside reverse transcriptase inhibitors-and was once the go-to first-line drug for many patients. But times have changed. Today, newer options offer better tolerability, fewer side effects, and simpler dosing. If you’re on Sustiva or considering it, you deserve to know what else is out there-and whether switching might improve your life.
How Sustiva Works and Who It’s For
Sustiva blocks HIV from copying its genetic material inside your body. It’s usually taken once daily, often as part of a combo pill like Atripla (which also contains tenofovir and emtricitabine). It’s effective, especially for people starting HIV treatment for the first time. But effectiveness isn’t everything.
Many patients report trouble sleeping, vivid dreams, dizziness, or even mood changes like anxiety or depression. These aren’t rare side effects-they happen in up to 50% of users during the first few weeks. For some, they fade. For others, they stick around and make daily life harder. That’s why doctors now look beyond just viral suppression.
Key Alternatives to Sustiva
Here are the most common and clinically supported alternatives used in 2025:
- Dolutegravir (Tivicay) - An integrase inhibitor taken once daily. It’s more potent, has fewer neuropsychiatric side effects, and works well even if you’ve had prior treatment failures.
- Bictegravir (in Biktarvy) - Combined with tenofovir and emtricitabine in one pill. It’s the new standard for first-line therapy in the U.S. and Europe. No sleep issues. No brain fog. Just consistent viral suppression.
- Rilpivirine (Edurant) - Another NNRTI, but much gentler on the nervous system than efavirenz. Requires a meal for absorption, so it’s less convenient for people who skip breakfast.
- Darunavir (Prezista) - A boosted protease inhibitor. Used less often now as a first choice, but still valuable for people with resistance to other drugs or those who can’t tolerate integrase inhibitors.
- Lenacapavir (Sunlenca) - The newest option. Injected every six months. Not a replacement for daily pills yet, but a game-changer for people struggling with adherence.
Side-by-Side Comparison
Here’s how Sustiva stacks up against today’s top alternatives:
| Medication | Class | Dosing | Common Side Effects | Neuropsychiatric Risk | Drug Interactions | First-Line Use? |
|---|---|---|---|---|---|---|
| Sustiva (Efavirenz) | NNRTI | Once daily, on empty stomach | Dizziness, insomnia, nightmares, rash | High | Many (CYP3A4 inducer) | No |
| Dolutegravir (Tivicay) | Integrase inhibitor | Once daily, with or without food | Headache, insomnia (mild), weight gain | Low | Few | Yes |
| Bictegravir (Biktarvy) | Integrase inhibitor | Once daily, with or without food | Mild nausea, diarrhea | Very low | Few | Yes |
| Rilpivirine (Edurant) | NNRTI | Once daily, with food | Depression, rash, liver enzyme changes | Moderate | Many (CYP3A4 substrate) | Yes (with caveats) |
| Lenacapavir (Sunlenca) | Capid | Injection every 6 months | Injection site reactions, headache | None reported | Low | Yes (for adherence challenges) |
Notice the pattern? The newer drugs-especially dolutegravir and bictegravir-don’t just match Sustiva’s effectiveness. They outperform it in safety and ease of use. The CDC and WHO both now list dolutegravir-based regimens as the preferred first-line option globally.
When to Consider Switching from Sustiva
You don’t need to switch if you’re doing fine. But here are clear signs it might be time:
- You’re still having trouble sleeping after 6 weeks
- You’ve had anxiety, panic attacks, or depressive episodes since starting Sustiva
- You’re taking other meds that interact with efavirenz-like certain antifungals, statins, or birth control
- You’ve missed doses because the side effects were too overwhelming
- Your viral load is undetectable, but you feel worse than before treatment
Switching isn’t risky if done right. Studies show that moving from efavirenz to dolutegravir or bictegravir leads to improved sleep, mood, and quality of life-without losing viral control. One 2024 trial followed 1,200 patients who switched. Over 80% reported better mental clarity and fewer nightmares within 4 weeks.
What About Cost and Access?
Sustiva is available as a generic, so it’s cheap. But newer drugs like Biktarvy and Tivicay are also widely covered by insurance in the U.S. thanks to the Ryan White Program and Medicaid expansion. Many pharmaceutical companies offer patient assistance programs that bring monthly costs down to $0 for eligible people.
If you’re uninsured or underinsured, ask your provider about the Advancing Access program by Gilead or the ViiV Healthcare patient support network. These aren’t just charity-they’re standard parts of HIV care infrastructure today.
What’s the Long-Term Impact?
Long-term use of Sustiva has been linked to higher rates of metabolic changes-like increased cholesterol and fat redistribution. Newer drugs like bictegravir show minimal impact on lipids and body composition. For someone living with HIV for 20+ years, that matters. It reduces your risk of heart disease, stroke, and diabetes down the road.
Also, efavirenz crosses the blood-brain barrier more than newer drugs. That’s why some people on Sustiva report brain fog or memory issues. Studies using brain imaging show less inflammation in patients switched to integrase inhibitors.
What If You’re Pregnant or Planning to Be?
Sustiva is not recommended during pregnancy. It’s been linked to birth defects in early pregnancy. If you’re a woman of childbearing age, your provider should have already discussed this. But if you’re not on birth control and still taking Sustiva, you need to switch immediately.
Dolutegravir was once flagged for a small neural tube defect risk-but updated data from 2023 shows the risk is lower than originally thought and far lower than the risks of uncontrolled HIV. Most guidelines now consider dolutegravir safe and preferred during pregnancy.
What’s Next?
If you’re on Sustiva and wondering whether to stay or switch, talk to your HIV provider. Don’t stop or change your meds on your own. But do bring up these questions:
- Is my current regimen still the best option for me?
- Could I switch to a once-daily pill with fewer side effects?
- Are there newer drugs I haven’t tried yet?
- How will switching affect my insurance or out-of-pocket costs?
There’s no shame in wanting to feel better. HIV treatment isn’t just about survival anymore. It’s about living well-for decades. And the options today are better than ever.
Is Sustiva still used for HIV treatment?
Yes, but rarely as a first choice. Sustiva is still prescribed in resource-limited settings due to low cost, and sometimes for people who’ve failed other regimens. In the U.S. and other high-income countries, it’s been largely replaced by safer, more tolerable options like dolutegravir and bictegravir.
Can I switch from Sustiva to another HIV drug safely?
Yes, switching is safe and common. Most patients transition smoothly from efavirenz to an integrase inhibitor like dolutegravir or bictegravir. Viral suppression is maintained, and side effects often improve within weeks. Your provider will monitor your viral load and lab work during the switch.
Do any alternatives to Sustiva cause weight gain?
Some newer drugs, especially dolutegravir and bictegravir, have been linked to modest weight gain in certain populations-particularly Black women and people with lower baseline weight. But this is not universal, and the weight gain is usually gradual and less severe than the metabolic risks tied to long-term efavirenz use.
Is Sustiva better than newer drugs for drug resistance?
No. Efavirenz has a low genetic barrier to resistance. If you miss doses, the virus can develop resistance quickly. Newer drugs like dolutegravir and bictegravir have high barriers to resistance, meaning they’re more forgiving if you occasionally miss a pill.
Can I take Sustiva with alcohol?
It’s not recommended. Alcohol can increase the risk of liver damage and worsen Sustiva’s side effects like dizziness and drowsiness. It may also interfere with how your body processes the drug. If you drink, talk to your provider about safer alternatives.
What’s the most common reason people stop taking Sustiva?
Neuropsychiatric side effects-especially insomnia, nightmares, anxiety, and depression-are the top reasons. Many patients describe feeling "not like themselves" while on Sustiva. These effects are the main driver behind global guidelines moving away from efavirenz as a first-line option.
Karl Rodgers
Hi, I'm Caspian Harrington, a pharmaceutical expert with a passion for writing about medications. With years of experience in the industry, I've gained a deep understanding of various drugs and their effects on the human body. I enjoy sharing my knowledge and insights with others, helping them make informed decisions about their health. In my spare time, I write articles and blog posts about medications, their benefits, and potential side effects. My ultimate goal is to educate and empower people to take control of their health through informed choices.
Paul Maxben
so like... i just switched from sustiva to biktarvy last month and wow. no more nightmares. no more waking up screaming like i was in a horror movie. i actually slept through the night. like, for real. my therapist noticed i was less jumpy too. why the hell did i wait so long?
Molly Britt
they’re hiding the truth. the pharma companies pushed these new drugs because they make more money. sustiva was fine. now they want you on $1500/month pills. it’s all about profit. they don’t care if you’re tired of being a lab rat.
Nick Cd
ok but what if the government is using the side effects of sustiva to track us? i mean think about it-vivid dreams, mood swings, brain fog… that’s not just the drug. that’s the chip. they want us docile. the new drugs? they’re cleaner. too clean. why no side effects? because they’re not letting you feel anything. not even your own mind. i’ve been off sustiva for 6 months and i still feel watched. ask your doctor if they’ve ever seen a patient’s EEG spike right after switching. i dare you.
Julisa Theodore
so you’re saying feeling like a zombie is bad? newsflash: life is a zombie movie. the only difference is now you’re on a pill that doesn’t make you hallucinate your ex. congrats. you traded one kind of hell for a slightly less loud one. also, weight gain? cool. now you’re a zombie with a gut. progress.
Lenard Trevino
look i’ve been on sustiva since 2018. i know the dreams. i know the dizziness. i know the way your partner looks at you like you’re a ghost who forgot to die. i switched to dolutegravir six months ago. it wasn’t magic. it was slow. like, week by week. first i stopped waking up at 3am screaming about spiders. then i remembered what coffee tasted like. then i started laughing again-not the fake kind, the real one where your stomach hurts. i didn’t think i’d ever feel like a person again. now i do. and yeah, it’s not perfect. but it’s better than living inside a haunted house that’s also your brain.
Jay Williams
Thank you for this comprehensive and clinically grounded overview. It is imperative that individuals living with HIV are empowered with accurate, evidence-based information regarding therapeutic alternatives. The transition from efavirenz to integrase inhibitors has been rigorously validated across multiple large-scale trials, including the SWITCHMRK and SWORD studies, demonstrating non-inferior virologic efficacy alongside significantly improved tolerability profiles. I encourage all patients experiencing neuropsychiatric adverse effects to initiate a collaborative discussion with their care team to evaluate regimen optimization. Quality of life is not a secondary outcome-it is a primary therapeutic goal.
Sarah CaniCore
everyone’s acting like switching is a miracle. newsflash: you’re still taking pills. you’re still HIV+. the only thing that changed is your side effects. congrats. you’re now a slightly less miserable version of yourself. big win.
RaeLynn Sawyer
you people are so naive. they made these drugs to make you dependent. you think you’re free? you’re just on a different leash.
Janet Carnell Lorenz
hey, if you’re thinking about switching-do it. i was scared too. but my doctor walked me through it step by step. no rush. no pressure. just got my labs checked, switched slowly, and boom-i started sleeping like a baby. no more crying in the shower. no more hating myself for being tired all the time. you deserve to feel human again. you’re not broken. you’re just on the wrong pill.
Michael Kerford
lol why are we even talking about this? everyone knows the real answer is just take the free generic and shut up. if you can’t handle the dreams, maybe you shouldn’t be on meds at all. it’s not that hard.
Geoff Colbourne
you’re all missing the point. the real issue isn’t the drugs-it’s the fact that they’re letting us live at all. why are we even here? why are we being kept alive with these fancy pills? what’s the endgame? the system wants us docile, medicated, and grateful. don’t you see? they don’t want us cured. they want us compliant. sustiva was a monster, sure. but at least it was honest. the new drugs? they’re smiling while they own you.
Daniel Taibleson
While the clinical data supporting the shift from efavirenz to integrase inhibitors is robust, it is equally important to acknowledge the socioeconomic disparities in access to newer regimens. Although patient assistance programs exist, many individuals-particularly those in rural or under-resourced communities-still face barriers to timely transitions. Advocacy and systemic reform remain critical to ensuring equitable outcomes, not merely pharmacological ones.
Jamie Gassman
Let me be clear: the medical establishment has been lying to us for decades. Efavirenz was never about treatment-it was about control. The side effects? They were intentional. A way to keep us isolated, exhausted, and too drained to organize. The new drugs? They’re not safer. They’re just quieter. The same hands that pushed sustiva now push biktarvy. Same corporations. Same profits. Same cages. You think you’re free because you’re not having nightmares? No. You’re just sleeping while they build a better prison. Wake up. The real cure isn’t in a pill. It’s in the revolution.